- Home
- MLAB vs PRTA Comparison
MLAB vs PRTA Comparison
Compare MLAB & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- PRTA
- Stock Information
- Founded
- MLAB 1982
- PRTA 2012
- Country
- MLAB United States
- PRTA Ireland
- Employees
- MLAB N/A
- PRTA N/A
- Industry
- MLAB Industrial Machinery/Components
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- MLAB Industrials
- PRTA Health Care
- Exchange
- MLAB Nasdaq
- PRTA Nasdaq
- Market Cap
- MLAB 680.0M
- PRTA 809.8M
- IPO Year
- MLAB N/A
- PRTA N/A
- Fundamental
- Price
- MLAB $117.96
- PRTA $12.22
- Analyst Decision
- MLAB Hold
- PRTA Buy
- Analyst Count
- MLAB 2
- PRTA 9
- Target Price
- MLAB $140.00
- PRTA $54.57
- AVG Volume (30 Days)
- MLAB 48.0K
- PRTA 452.5K
- Earning Date
- MLAB 02-04-2025
- PRTA 05-07-2025
- Dividend Yield
- MLAB 0.54%
- PRTA N/A
- EPS Growth
- MLAB N/A
- PRTA N/A
- EPS
- MLAB N/A
- PRTA N/A
- Revenue
- MLAB $237,747,000.00
- PRTA $135,157,000.00
- Revenue This Year
- MLAB $13.48
- PRTA N/A
- Revenue Next Year
- MLAB $4.74
- PRTA $131.75
- P/E Ratio
- MLAB N/A
- PRTA N/A
- Revenue Growth
- MLAB 11.68
- PRTA 47.92
- 52 Week Low
- MLAB $83.68
- PRTA $11.70
- 52 Week High
- MLAB $155.12
- PRTA $26.36
- Technical
- Relative Strength Index (RSI)
- MLAB 37.05
- PRTA 35.87
- Support Level
- MLAB $121.89
- PRTA $12.46
- Resistance Level
- MLAB $130.12
- PRTA $13.52
- Average True Range (ATR)
- MLAB 4.45
- PRTA 0.73
- MACD
- MLAB -0.25
- PRTA -0.10
- Stochastic Oscillator
- MLAB 18.72
- PRTA 9.18
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).